SAGE   $8.68  -0.23% Market Closed

Sage Therapeutics, Inc.
Total Cash 569.15M
totalCashPerShare 9.304
EBITDA -371.15M
Total Debt 10.27M
quickRatio 9.721
currentRatio 10.015
Total Revenue 106.40M
debtToEquity 1.862
Revenue/Share 1.76
ROA -0.29615
ROE -0.49338
grossProfits
freeCashflow -217.68M
operatingCashflow -320.15M
earningsGrowth
revenueGrowth 3.371
grossMargins -1.49584
ebitdaMargins 0.0
operatingMargins -8.52515
profitMargins 0.0
enterpriseValue -195.51M
forwardPE -1.4382566
floatShares 48.46M
sharesOutstanding 61.17M
sharesShort 6.11M
sharesShortPriorMonth 5.82M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.89%
Short Ratio help_outline 9.76%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 9.021
Price To Book help_outline 0.66
earningsQuarterlyGrowth
netIncomeToCommon -337.59M
trailingEps -5.57%
forwardEps -4.13%
enterpriseToEbitda 0.53
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.56 4Q 2024
institutionsCount 274
lastUpdated Nov. 6, 2024, 5:26 p.m.